Deleted Tweets From Scott Gottlieb, R-D.C.

RT @FDA_ORA: Happy New Years from #FDAORA! https://t.co/SyEIvZuu0p

#FDA is working closely with industry and local & federal officials to address shortage of IV saline as a result of Hurricane Maria. This remains a key area of focus. We expect shortage of IV fluids will improve in early 2018 based on information we'r

In the meantime, we're continuing all of our efforts to increase supplies while concerns remain. Please see #FDA's statement on the ways we continue to work to address this shortage. We'll have another update shortly after the New Year https://t.co/Dcl4Sj

FDA Voice by @FDAOncology Rick Pazdur: In cancer treatment, there's more than one way to measure patient benefit https://t.co/945iGf8fOy @realrickpazdur

RT @FDAWomen: Although dietary supplements can help support good #health, they may also cause side effects and health problems. G… https://t.co/hcD0icRzvD

RT @chrissyfarr: So I had a few questions for @SGottliebFDA https://t.co/eyzpXRrvet QT @CNBC: FDA chief: I'm surprised it took big tech this long to get into health care https://t.co/b5s8YLNIx8)

New digital health technology provides more ways to inform consumers, advance health. Our policies in 2018 will encourage the safe, effective development of these beneficial opportunities https://t.co/IP3FhZLeu5

3/3 Americans MUST have confidence FDA acts quickly in setting of food recalls to protect them. This is core of our consumer protection role. We’ve improved much; will prove it with updated data; and will make the process even better in 2018. Wish everyon

1/3 This report, first released in 2016, was re-released over Christmas. It’s based on a selective review of 30 complex food recalls from 2012-2015 out of 1,000s performed. In many of the 30 FDA was slow to act. Even a few flawed recalls are too many. We QT @NYTHealth: Federal investigators say the F.D.A. must get tainted foods off the shelves faster to protect consumers from illness https://t.co/s0fP1NHuuL)

2/3 We made MANY processs improvements to speed food recalls; increase our rigor. We’ll release updated analysis - from 2017 NOT 2012 - on how we’re doing. More reforms in store for 2018; including changes to make sure we release much more info to consume

#FDA Workshop: Weighing the Evidence - Variant Classification and Interpretation in Precision Oncology - to discuss how #genetic #sequencing data is best implemented in patient management. Jan 29 at FDA or online https://t.co/8d9TfMaoU5 #NGS

RT @FDAOncology: .@FDAOncology perspective: Evaluating Endpoints & Evidence in Era of Breakthrough Therapies @OncJournal https://t.co/NuD9lM1qoz

Happy New Year from people of #FDA: 2017 saw innovations in science that are transforming health. We also faced challenges; an opioid crisis that’s destroying families. In 2018 we’ll leverage science to improve lives, and reduce suffering from disease, ad

RT @FDA_ORA: Did you make a resolution to quit smoking? Check out these FDA-approved products that can help you on your way to b… https://t.co/UAt4mL6z1p

RT @ElizabethJungma: ICYMI: "Much of the patient harm caused by compounded drugs is preventable . . . " Toward Better-Quality Compounded… https://t.co/phXZUAfwXZ

RT @fdalawblog: FDA “Finalizes” Rule on Health Care Antiseptic Drug Products Ahead of Time - https://t.co/MZEAOAYAIv

What's happening at the #FDA Oncology Center of Excellence? Check out our website https://t.co/orTiNvYG0Q @FDAOncology

RT @FDAOncology: Did you know FDA has a webpage for patients and a calendar of public meetings? https://t.co/nq7KW6G631

#FDA will advance more policies in 2018 to open new avenues to generic entry. Coupled with the increasing efficiency and high performance of our generic review program; we expect 2018 to register even more generic approvals than our record-setting 2017 ht

RT @US_FDA: Questions about the FDA #patientengagement collaborative? Join us for a call with FDA and @CTTI_Trials on January 1… https://t.co/EYI6ZASuXE

RT @FDA_ORA: Happy New Years from #FDAORA! https://t.co/SyEIvZuu0p

#FDA is working closely with industry and local & federal officials to address shortage of IV saline as a result of Hurricane Maria. This remains a key area of focus. We expect shortage of IV fluids will improve in early 2018 based on information we'r

In the meantime, we're continuing all of our efforts to increase supplies while concerns remain. Please see #FDA's statement on the ways we continue to work to address this shortage. We'll have another update shortly after the New Year https://t.co/Dcl4Sj

FDA Voice by @FDAOncology Rick Pazdur: In cancer treatment, there's more than one way to measure patient benefit https://t.co/945iGf8fOy @realrickpazdur

RT @FDAWomen: Although dietary supplements can help support good #health, they may also cause side effects and health problems. G… https://t.co/hcD0icRzvD

RT @chrissyfarr: So I had a few questions for @SGottliebFDA https://t.co/eyzpXRrvet QT @CNBC: FDA chief: I'm surprised it took big tech this long to get into health care https://t.co/b5s8YLNIx8)

New digital health technology provides more ways to inform consumers, advance health. Our policies in 2018 will encourage the safe, effective development of these beneficial opportunities https://t.co/IP3FhZLeu5

3/3 Americans MUST have confidence FDA acts quickly in setting of food recalls to protect them. This is core of our consumer protection role. We’ve improved much; will prove it with updated data; and will make the process even better in 2018. Wish everyon

1/3 This report, first released in 2016, was re-released over Christmas. It’s based on a selective review of 30 complex food recalls from 2012-2015 out of 1,000s performed. In many of the 30 FDA was slow to act. Even a few flawed recalls are too many. We QT @NYTHealth: Federal investigators say the F.D.A. must get tainted foods off the shelves faster to protect consumers from illness https://t.co/s0fP1NHuuL)

2/3 We made MANY processs improvements to speed food recalls; increase our rigor. We’ll release updated analysis - from 2017 NOT 2012 - on how we’re doing. More reforms in store for 2018; including changes to make sure we release much more info to consume

#FDA Workshop: Weighing the Evidence - Variant Classification and Interpretation in Precision Oncology - to discuss how #genetic #sequencing data is best implemented in patient management. Jan 29 at FDA or online https://t.co/8d9TfMaoU5 #NGS

RT @FDAOncology: .@FDAOncology perspective: Evaluating Endpoints & Evidence in Era of Breakthrough Therapies @OncJournal https://t.co/NuD9lM1qoz

Happy New Year from people of #FDA: 2017 saw innovations in science that are transforming health. We also faced challenges; an opioid crisis that’s destroying families. In 2018 we’ll leverage science to improve lives, and reduce suffering from disease, ad

RT @FDA_ORA: Did you make a resolution to quit smoking? Check out these FDA-approved products that can help you on your way to b… https://t.co/UAt4mL6z1p

RT @ElizabethJungma: ICYMI: "Much of the patient harm caused by compounded drugs is preventable . . . " Toward Better-Quality Compounded… https://t.co/phXZUAfwXZ

RT @fdalawblog: FDA “Finalizes” Rule on Health Care Antiseptic Drug Products Ahead of Time - https://t.co/MZEAOAYAIv

What's happening at the #FDA Oncology Center of Excellence? Check out our website https://t.co/orTiNvYG0Q @FDAOncology

RT @FDAOncology: Did you know FDA has a webpage for patients and a calendar of public meetings? https://t.co/nq7KW6G631

#FDA will advance more policies in 2018 to open new avenues to generic entry. Coupled with the increasing efficiency and high performance of our generic review program; we expect 2018 to register even more generic approvals than our record-setting 2017 ht

RT @US_FDA: Questions about the FDA #patientengagement collaborative? Join us for a call with FDA and @CTTI_Trials on January 1… https://t.co/EYI6ZASuXE